Q: I have a few shares in Salix Pharmaceuticalds which is in the process of potentially being acquired by Valeant. There is a significant breakup fee if Salix does not go through with the sale which would seem to be a barrier to a competitive bid coming forward. Salix is currently trading $2 below the Valent offer of $158 perhaps because there is always a chance that the transaction will not close.
Should I sell my shares or wait to see if a better offer is tendered?
As always, thank you for your advice.
Don
Should I sell my shares or wait to see if a better offer is tendered?
As always, thank you for your advice.
Don